PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?-Reference-Cited by-同舟云学术

PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?

Published:2023-11 Issue:11 Volume:7 Page:e965
ISSN:2572-9241
Container-title:HemaSphere
language:en
Short-container-title:

Author:

Vassilakopoulos Theodoros P.¹,Piperidou Alexia¹,Mellios Zois²,Verigou Evgenia³,Katodritou Eirini⁴,Kalpadakis Christina⁵,Papageorgiou Sotirios G.⁶,Chatzidimitriou Chrysovalantou¹,Prassopoulos Vassilios⁷,Siakantaris Marina P.¹,Giatra Hara²,Karantanis Dimitrios⁸,Papathanasiou Nikolaos⁹,Ligdi Loukia²,Kopsaftopoulou Anastasia¹,Leonidopoulou Theoni¹⁰,Xanthopoulos Vasileios¹¹,Karakatsanis Stamatios¹²,Vrakidou Effimia⁷,Chatziioannou Sophia¹³,Drougkas Dimitrios¹⁴,Hatzimichael Eleftheria¹⁵,Gainaru Gabriella⁷,Palassopoulou Maria¹⁶,Tsirogianni Maria¹⁷,Kotsopoulou Maria¹⁸,Tsourouflis Gerassimos¹⁹,Skoura Evangelia²⁰,Mainta Catherine²¹,Terpos Evangelos²²,Poziopoulos Christos²³,Triantafyllou Theodora⁴,Zikos Panayiotis²⁴,Koumarianou Argyro²⁵,Liapi Dimitra²⁶,Pappa Vassiliki⁶,Verrou Evgenia⁴,Tsirigotis Panayiotis⁶,Labropoulou Vassiliki³,Papadaki Helen⁵,Datseris Ioannis²⁷,Symeonidis Argiris³,Bouzani Maria²,Bakiri Maria²,Karmiris Themis²,Angelopoulou Maria K.¹,Rondogianni Phivi²⁷

Affiliation:

1. Department of Haematology and Bone Marrow Transplantation, National and Kapodistrian University of Athens, Laikon General Hospital, Greece

2. Department of Hematology and Lymphoma, Evangelismos General Hospital, Athens, Greece

3. Department of Internal Medicine, Hematology Division, University of Patras, Rion, Greece

4. Department of Hematology, Theagenion Cancer Hospital, Thessaloniki, Greece

5. Department of Hematology, University of Crete, Iraklion, Greece

6. Second Department of Internal Medicine, Propaedeutic, Hematology Unit, National and Kapodistrian University of Athens, University General Hospital “Attikon,” Greece

7. Hygeia Hospital, Athens, Greece

8. Department of Nuclear Medicine, Iatropolis, Athens, Greece

9. Department of Nuclear Medicine, University Hospital of Patras, Rion, Greece

10. Department of Hematology, Sismanoglion General Hospital, Athens, Greece

11. Department of Hematology, Hygeia Hospital, Athens, Greece

12. Third Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Athens, Greece

13. Department of Nuclear Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, Greece

14. Department of Nuclear Medicine and PET/CT, Vioiatriki, Thessaloniki, Greece

15. Department of Hematology, University of Ioannina, Greece

16. Department of Hematology, University of Thessalia Hospital, Larissa, Greece

17. Department of Hematology, Saint Savvas Anticancer Hospital, Athens, Greece

18. Department of Hematology, Metaxa Anticancer Hospital, Piraeus, Greece

19. Second Department of Surgery, Propedeutic, National and Kapodistrian University of Athens, Laikon General Hospital, Greece

20. Department of Nuclear Medicine and PET/CT, Vioiatriki, Athens, Greece

21. Department of Nuclear Medicine and PET/CT, Athens Medical Center, Greece

22. Department of Therapeutics, National and Kapodistrian University of Athens, Alexandra Hospital, Greece

23. Department of Hematology, Metropolitan Hospital, N. Faliron, Athens, Greece

24. Haematology Unit, General Hospital of Patras “Agios Andreas,” Greece

25. First Department of Hematology, Metropolitan General Hospital, Athens, Greece

26. Department of Hematology, Venizelion Hospital, Iraklion, Crete, Greece

27. Department of Nuclear Medicine and PET/CT, Evangelismos General Hospital, Athens, Greece

Publisher

Wiley

Subject

Hematology

Reference25 articles.

1. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.;Vassilakopoulos;Oncologist,2012

2. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.;Savage;Ann Oncol,2006

3. Primary mediastinal B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: results of the Mabthera International Trial Group study.;Rieger;Ann Oncol,2011

4. PET/CT in primary mediastinal large B-cell lymphoma responding to rituximab-CHOP: An analysis of 106 patients regarding prognostic significance and implications for subsequent radiotherapy.;Vassilakopoulos;Leukemia,2016

5. Positron emission tomography after response to rituximab-CHOP in primary mediastinal large B-cell lymphoma: impact on outcomes and radiotherapy strategies.;Vassilakopoulos;Ann Hematol,2021